pigmented nodular adrenocortical disease, primary, 1

Rare Disease

MONDO:0012509

Also known as:

PRKAR1A primary pigmented nodular adrenocortical diseasepigmented nodular adrenocortical disease, primary, 1pigmented nodular adrenocortical disease, primary, type 1

Any primary pigmented nodular adrenocortical disease in which the cause of the disease is a mutation in the PRKAR1A gene.

Genes

Clinical Trials

–

Newborn Screening

–

Patient Groups

–

Patient-Friendly Information

Comprehensive, easy-to-understand information about this condition

How we create this content →

Report Generation Failed

We couldn't automatically generate the report. This may be due to temporary service issues.

Need this data in your product?

Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.

Explore API Start Free

← Back to All Diseases

Companies Active in pigmented nodular adrenocortical disease, primary, 1

3 companies

Organizations with orphan designations or approved therapies for this disease

BioRamo, LLC

Other

Designated

Daiichi Sankyo Inc.

Other

Designated

HRA Pharma

Other

Designated

View all companies